Outcome Total , % (n) Quintile for DII Quintile for DII Quintile for DII Quintile for DII Quintile for DII
Q1 (most pro-inflammatory group) Q2 Q3 Q4 Q5 (most anti-inflammatory group) p-value
PTB < 37 wks,
Endometriosis (-) 4.5 (3844/84900) 4.5 4.5 4.5 4.3 4.8 0.715
Endometriosis (+) 6.2 (202/3236) 6.7 6.5 6.1 6.6 5.5 0.454
PTB < 34 wks,
Endometriosis (-) 0.9 (786/84900) 1.1 0.9 0.8 0.9 0.9 0.094
Endometriosis (+) 1.2 (38/3236) 2.4 1.1 0.9 1.1 0.8 0.040
LBW < 2500 g,
Endometriosis (-) 7.9 (6720/84873) 8.4 8.3 7.5 7.4 8.0 0.008
Endometriosis (+) 10.0 (323/3238) 11.4 10.7 9.6 10.9 8.0 0.075
LBW < 1500 g,
Endometriosis (-) 0.5 (453/84873) 0.6 0.6 0.5 0.5 0.6 0.410
Endometriosis (+) 0.7 (24/3238) 2.2 0.5 0.6 0.7 0.3 0.003
HDP
Endometriosis (-) 2.8 (2363/85149) 3.0 2.8 2.7 2.6 2.7 0.060
Endometriosis (+) 3.2 (105/3249) 4.5 2.3 2.4 3.9 3.4 0.983